InsidersTradesSigma
Follow the Corline Biomedical AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Corline Biomedical AB has recorded 1 insider filings. Market capitalisation: €462.6m. The latest transaction was reported on 17 February 2026 (Purchase). Among the most active insiders: Henrik Nittmar. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Corline Biomedical AB 是一家专注于开发生物制药产品的公司。该公司专门为治疗严重疾病提供创新解决方案。